A re-irradiation dose of 55–60 Gy improves the survival rate of patients with local recurrent esophageal squamous cell carcinoma after radiotherapy

A re-irradiation dose of 55–60 Gy improves the survival rate of patients with local recurrent esophageal squamous cell carcinoma after radiotherapy

Abstract Introduction Local recurrence (LR) is clinical challenge in the treatment of esophageal squamous cell carcinoma (ESCC). The current study aimed to determine the optimal re-irradiation dose for local recurrent esophageal squamous cell carcinoma (LRESCC) following radical (chemo) radiotherapy...

Full description

Bibliographic Details
Main Authors:	Xun Wu, Xingsheng Hu, Junru Chen, Lang He
Format:	Article
Language:	English
Published:	BMC 2021-06-01
Series:	Radiation Oncology
Subjects:	Esophageal squamous cell carcinoma Recurrence Salvage chemoradiation therapy Salvage radiation therapy
Online Access:	https://doi.org/10.1186/s13014-021-01828-z

Similar Items

Multidisciplinary treatment of esophageal cancer: The role of active surveillance after neoadjuvant chemoradiation
by: Tania Triantafyllou, et al.
Published: (2020-07-01)

Patterns of recurrence after surgery and efficacy of salvage therapy after recurrence in patients with thoracic esophageal squamous cell carcinoma
by: Wenjie Ni, et al.
Published: (2020-02-01)

Outcomes and Prognostic Factors of Salvage Radiation for Postoperative Lymph Node Recurrence of Esophageal Squamous Cell Carcinoma
by: Chi Zhang, et al.
Published: (2021-03-01)

Salvage concurrent radio-chemotherapy for post-operative local recurrence of squamous-cell esophageal cancer
by: Zhang Jian, et al.
Published: (2012-06-01)

Combination of Oxaliplatin and 5-Fluorouracil/Leucovorin for Advanced Esophageal Squamous Cell Carcinoma Refractory or Intolerant to Standard Therapies
by: Seiichiro Mitani, et al.
Published: (2019-04-01)

Clinical observation of gene expression-guided chemoradiation therapy for nonsurgical esophageal squamous cell carcinoma patients: a retrospective analysis of 36 cases
by: Yang Z, et al.
Published: (2016-07-01)

A multicenter phase II study of salvage photodynamic therapy using talaporfin sodium (ME2906) and a diode laser (PNL6405EPG) for local failure after chemoradiotherapy or radiotherapy for esophageal cancer.
by: Yano, Tomonori
Published: (2017)

Long-term outcomes of the 2-week schedule of hypofractionated radiotherapy for recurrent hepatocellular carcinoma
by: Jongmoo Park, et al.
Published: (2018-10-01)

Risk Factors and On-site Rescue Treatments for Endoscopic Variceal Ligation Failure
by: Dong Hyun Kim, et al.
Published: (2018-10-01)

Whole-gland salvage treatment for recurrent prostate cancer after initial definitive radiotherapy: A case series of 125I brachytherapy and robot-assisted radical prostatectomy
by: Shinya Sutani, et al.
Published: (2019-06-01)

Simultaneous integrated boost for mediastinal lymph node recurrence after radical surgery for esophageal cancer: Interim results from a phase I/II prospective study
by: Wei‐xiang Qi, et al.
Published: (2021-04-01)

Outcomes of Definitive Chemoradiotherapy for Stage IVa (T4b vs. N4) Esophageal Squamous Cell Carcinoma based on the Japanese Classification System: A Retrospective Single-Center Study
by: Yuki Wada, et al.
Published: (2021-12-01)

Long-term outcome of irradiation with or without chemotherapy for esophageal squamous cell carcinoma: a final report on a prospective trial
by: Liu Mina, et al.
Published: (2012-08-01)

Salvage conformal radiotherapy for biochemical recurrent prostate cancer after radical prostatectomy
by: Carlos R. Monti, et al.
Published: (2006-08-01)

Salvage robot-assisted radical prostatectomy after brachytherapy: our experience
by: A. V. Govorov, et al.
Published: (2014-11-01)

Salvage robot-assisted radical prostatectomy after brachytherapy: our experience
by: A. V. Govorov, et al.
Published: (2014-11-01)

Salvage brachytherapy with or without external beam radiotherapy for oral or oropharyngeal squamous cell carcinomas in previously irradiated areas: carcinologic and toxicity outcomes of 25 patients
by: Pierre-Marie Pialat, et al.
Published: (2021-08-01)

Phase I study of photodynamic therapy using talaporfin sodium and diode laser for local failure after chemoradiotherapy for esophageal cancer
by: Yano Tomonori, et al.
Published: (2012-07-01)

Salvage surgery for local recurrence after carbon ion radiotherapy for lung cancer: A case report
by: Kantaro Hara, et al.
Published: (2020-01-01)

Outcomes and Prediction Models for Exclusive Prostate Bed Salvage Radiotherapy among Patients with Biochemical Recurrence after Radical Prostatectomy
by: Chi-Shin Tseng, et al.
Published: (2021-05-01)

Salvage radiotherapy for recurrent hypopharyngeal and laryngeal squamous cell carcinoma (SCC) after first-line treatment with surgery alone: a 10-year single-centre experience
by: Sati Akbaba, et al.
Published: (2019-02-01)

Lung adenocarcinoma with tumor resolution and dystrophic calcification after salvage surgery following immune checkpoint inhibitor therapy: A case report
by: Toshiyuki Sumi, et al.
Published: (2020-11-01)

Posaconazole as rescue therapy in African histoplasmosis
by: Daniel Gonçalves, et al.

Posaconazole as rescue therapy in African histoplasmosis
by: Daniel Gonçalves, et al.
Published: (2013-02-01)

Salvage therapy for progressive, treatment-refractory or recurrent pediatric medulloblastoma: a systematic review protocol
by: Ashley A. Adile, et al.
Published: (2020-03-01)

Etoposide Therapy for Recurrent Gliomas
by: J Gordon Millichap
Published: (1997-06-01)

Chemoradiation with Weekly Paclitaxel and Carboplatin in Esophageal Squamous Cell Carcinoma: A Prospective Study
by: Deepa M. Joseph, et al.
Published: (2021-09-01)

Salvage radical prostatectomy: an alternative treatment for local recurrence of radioresistant cancer
by: Marcos F. Dall'Oglio, et al.
Published: (2006-10-01)

Post-Surgical Strategies for Prostate Cancer: Clinicopathologic and Genomics Criteria
by: Alessandro Morlacco, et al.
Published: (2017-10-01)

Prognostic Impact of Pretreatment Serum CYFRA Status in 1047 Patients with Esophageal Squamous Cell Carcinoma Who Underwent Radical Resection: A Japan Esophageal Society Promotion Research
by: Fukuda, T., et al.
Published: (2022)

Prostate Cancer – Local Treatment after Radiorecurrence: Surgery - Back to the future?
by: Leonardo O. Reis, et al.

Efficacy of Salvage Interferential Electrical Stimulation Therapy in Patients With Medication-Refractory Enuresis: A Pilot Study
by: Hahn-Ey Lee, et al.
Published: (2013-09-01)

Dysfunction of apoptosis and autophagy correlates with local recurrence in esophageal squamous cell carcinoma after definitive chemoradiation
by: Hu Qiu, et al.
Published: (2021-09-01)

Worth a local treatment? – Analysis of modern radiotherapy concepts for oligometastatic prostate cancer
by: M. Oertel, et al.
Published: (2018-09-01)

YAP1 amplification as a prognostic factor of definitive chemoradiotherapy in nonsurgical esophageal squamous cell carcinoma
by: Honghai Dai, et al.
Published: (2020-03-01)

Reconstruction in previously irradiated patients
by: Chaudhari Charudatta
Published: (2007-12-01)

Studies of Intra-Fraction Prostate Motion During Stereotactic Irradiation in First Irradiation and Re-Irradiation
by: Alexandre Taillez, et al.
Published: (2021-07-01)

The Impact of Radiation to Epicardial Adipose Tissue on Prognosis of Esophageal Squamous Cell Carcinoma Receiving Neoadjuvant Chemoradiotherapy and Esophagectomy
by: Hung-Chi Tai, et al.
Published: (2021-04-01)

Salvage re-irradiation using stereotactic body radiation therapy for locally recurrent prostate cancer: the impact of castration sensitivity on treatment outcomes
by: Ron Lewin, et al.
Published: (2021-06-01)

Retrospective observational study of salvage line ramucirumab monotherapy for patients with advanced gastric cancer
by: Sadayuki Kawai, et al.
Published: (2020-04-01)

Cannot write session to /tmp/vufind_sessions/sess_e2fhoqcdtknj5vvri7odvh87dj